Skip Navigation


Carcinogenesis Advance Access originally published online on August 18, 2006
Carcinogenesis 2007 28(2):465-470; doi:10.1093/carcin/bgl148
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/2/465    most recent
bgl148v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Johansson, K.
Right arrow Articles by Morgenstern, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johansson, K.
Right arrow Articles by Morgenstern, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Microsomal glutathione transferase 1 in anticancer drug resistance

Katarina Johansson*, Karin Åhlen, Rosanna Rinaldi1, Karin Sahlander2, Atchasai Siritantikorn3 and Ralf Morgenstern

Institute of Environmental Medicine, Division of Biochemical Toxicology, Karolinska Institutet SE-171 77 Stockholm, Sweden
1 Istituto Scientifico San Raffaele, via Olgettina 58 20132 Milano, Italy
2 Lung and Allergy Research, Division of Physiology, National Institute of Environmental Medicine, Karolinska Institutet Stockholm, Sweden
3 Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University BKK 10330, Thailand

*To whom correspondence should be addressed. Tel: +46 8 5248 7566; Fax: +46 8 343849; Email: katarina.johansson{at}ki.se

Glutathione transferases (GSTs) are often upregulated in tumors and have been suggested to play an important role in multiple drug resistance in cancer chemotherapy. As a consequence GST-dependent pro-drugs and inhibitors are being developed. Little is known, however, on the potential role of membrane-bound GSTs in drug resistance despite the fact that detoxication of cytostatic drugs and upregulation in tumors has been demonstrated. Therefore, we have studied the involvement of membrane-bound microsomal GST1 (MGST1) in cellular resistance to anticancer drugs. As a tool we have developed a cell system utilizing MCF7 cells stably overexpressing MGST1. Here, we show for the first time that MGST1 can protect cells from several cytostatic drugs, chlorambucil, melphalan and cisplatin in an acute toxicity test (MTT assay) as well as a long-term colony forming efficiency cytotoxicity test. It is of note that these cells do not overexpress multidrug transporters, a prerequisite for protection with certain other GSTs investigated in this system. The cytostatic drugs used comprise both those that are known/predicted to be substrates as well as non-substrates. Thus, the mechanism most probably entails both direct detoxication and downstream protection of the cells from oxidative stress.

Abbreviations: BSA, bovine serum albumin; CDNB, 1-chloro-2,4-dinitrobenzene; CFE, colony forming efficiency; DTNB, 5,5'-dithiobis-(2-nitrobenzoic acid); FBS, fetal bovine serum; G418, geneticin; GSH, glutathione; GST, glutathione transferase; GPX, glutathione peroxidase; MGST1, microsomal glutathione transferase 1; MTT, 3-[4,5-dimethylthiazol-2yl]-2,5-diphenyltetrazolium bromide; NEM, N-ethylmaleimide; SOD, superoxide dismutase

Received May 31, 2006; revised August 9, 2006; accepted August 11, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.